DFSVX
Price
$51.34
Change
+$0.10 (+0.20%)
Updated
Sep 5 closing price
Net Assets
16.85B
MVSSX
Price
$32.84
Change
+$0.51 (+1.58%)
Updated
Sep 4 closing price
Net Assets
1.07B
Interact to see
Advertisement

DFSVX vs MVSSX

Header iconDFSVX vs MVSSX Comparison
Open Charts DFSVX vs MVSSXBanner chart's image
DFA US Small Cap Value I
Price$51.34
Change+$0.10 (+0.20%)
VolumeN/A
Net Assets16.85B
Victory Integrity Small-Cap Value R6
Price$32.84
Change+$0.51 (+1.58%)
VolumeN/A
Net Assets1.07B
DFSVX vs MVSSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DFSVX vs. MVSSX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a Buy and MVSSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 16.8B vs. MVSSX (1.07B). MVSSX pays higher dividends than DFSVX: MVSSX (1.64) vs DFSVX (1.52). DFSVX was incepted earlier than MVSSX: DFSVX (33 years) vs MVSSX (13 years). MVSSX (0.96) is less costly to investors than DFSVX (0.31). MVSSX is a more actively managed with annual turnover of: 62.00 vs. DFSVX (12.00). DFSVX (0) and MVSSX (0) have matching initial minimum investment requirements. DFSVX annual gain was more profitable for investors over the last year : 11.40 vs. MVSSX (-7.66). DFSVX return over 5 years is better than : 94.21 vs. MVSSX (24.15).
DFSVXMVSSXDFSVX / MVSSX
Total Expense Ratio0.310.9632%
Annual Report Gross Expense Ratio0.310.9632%
Fund Existence33 years13 years-
Gain YTD6.7654.056167%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets16.8B1.07B1,575%
Annual Yield % from dividends1.521.6493%
Returns for 1 year11.40-7.66-149%
Returns for 3 years35.36-3.93-899%
Returns for 5 years94.2124.15390%
Returns for 10 years64.868.30781%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOAR76.482.75
+3.73%
Loar Holdings
GLUE4.940.03
+0.61%
Monte Rosa Therapeutics
JANX23.980.04
+0.17%
Janux Therapeutics
JPM294.38-9.44
-3.11%
JPMorgan Chase & Co
RENB0.21-0.01
-3.23%
Renovaro